Review Series - May 14, 2015

In this review series, introduced by Dr. Jesús San Miguel, leaders in the field of multiple myeloma (MM) discuss the fascinating pathogenetic scenarios of disease development, the evolution of monoclonal gammopathy of undetermined significance and smoldering myeloma to MM, the clinical importance and practice of minimal residual disease response assessment, and current first- and second-line therapeutic strategies.